Biblio

Export 115 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2019
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., “Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).”, J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
2018
E. L. Boespflug, Simon, M. J., Leonard, E., Grafe, M., Woltjer, R., Silbert, L. C., Kaye, J. A., and Iliff, J. J., “Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
S. Gauthier, Ng, K. Pin, Pascoal, T. A., Zhang, H., and Rosa-Neto, P., “Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.”, J Alzheimers Dis, vol. 64, no. s1, pp. S23-S31, 2018.
J. Hyun Lee, Jahrling, J. B., Denner, L., and Dineley, K. T., “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
P. Novak, Cehlar, O., Skrabana, R., and Novak, M., “Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation.”, J Alzheimers Dis, vol. 64, no. s1, pp. S535-S546, 2018.
E. M. Sigurdsson, “Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls.”, J Alzheimers Dis, vol. 64, no. s1, pp. S555-S565, 2018.
R. Pluta, Ułamek-Kozioł, M., Januszewski, S., and Czuczwar, S. J., “Tau Protein Dysfunction after Brain Ischemia.”, J Alzheimers Dis, vol. 66, no. 2, pp. 429-437, 2018.
J. P. Quinn, Corbett, N. J., Kellett, K. A. B., and Hooper, N. M., “Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.”, J Alzheimers Dis, vol. 63, no. 1, pp. 13-33, 2018.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., “Tauopathies: Mechanisms and Therapeutic Strategies.”, J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
A. Sahoo, Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., Knopman, D. S., Petersen, R. C., Dickson, D. W., Whitwell, J. L., and Josephs, K. A., “TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
M. E. Flanagan, Cholerton, B., Latimer, C. S., Hemmy, L. S., Edland, S. D., Montine, K. S., White, L. R., and Montine, T. J., “TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1549-1558, 2018.
S. G. Papageorgiou, Voskou, P., Economou, A., Beratis, I., and Douzenis, A., “Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 985-994, 2018.
C. Bussè, Caffarra, P., Rossi, A., Zorzi, G., Fragiacomo, F., Camporese, G., Pompanin, S., Di Bernardo, G. Antonio, and Cagnin, A., “Testing Hippocampal Memory in Prodromal Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 64, no. 2, pp. 349-353, 2018.
D. Angulo Sevilla, Rodríguez, M. Teresa Car, Rodríguez, P. Heredia, Sánchez, M. Fernández, Mora, J. Aurelio Vi, and Gago-Veiga, A. Beatriz, “Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?”, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.
F. J. Wolters, Adams, H. H. H., Bos, D., Licher, S., and M Ikram, A., “Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers.”, J Alzheimers Dis, vol. 64, no. s1, pp. S145-S159, 2018.
T. Hang Wong, Pottier, C., Hondius, D. C., Meeter, L. H. H., van Rooij, J. G. J., Melhem, S., van Minkelen, R., van Duijn, C. M., Rozemuller, A. J. M., Seelaar, H., Rademakers, R., and van Swieten, J. C., “Three VCP Mutations in Patients with Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1139-1146, 2018.
E. Guzmán-Vélez, Jaimes, S., Aguirre-Acevedo, D. C., Norton, D. J., Papp, K. V., Amariglio, R., Rentz, D., Baena, A., Henao, E., Tirado, V., Munoz, C., Giraldo, M., Sperling, R. A., Lopera, F., and Quiroz, Y. T., “A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 107-115, 2018.
I. Akushevich, Yashkin, A. P., Kravchenko, J., Ukraintseva, S., Stallard, E., and Yashin, A. I., “Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 137-148, 2018.
J. Miron, Picard, C., Frappier, J., Dea, D., Théroux, L., and Poirier, J., “TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1547-1556, 2018.
L. Wati Durani, Hamezah, H. Shahirah, Ibrahim, N. Faeizah, Yanagisawa, D., Nasaruddin, M. Luqman, Mori, M., Azizan, K. Azlan, Damanhuri, H. Ahmad, Makpol, S., Ngah, W. Zurinah Wa, and Tooyama, I., “Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 64, no. 1, pp. 249-267, 2018.
G. Banerjee, Jang, H., Kim, H. Jin, Kim, S. Tae, Kim, J. Seung, Lee, J. Hong, Im, K., Kwon, H., Lee, J. Min, Na, D. L., Seo, S. Won, and Werring, D. John, “Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1485-1497, 2018.
J. San Lee, Kim, S., Yoo, H., Park, S., Jang, Y. Kyoung, Kim, H. Jin, Kim, K. Woon, Kim, Y., Jang, H., Park, K. - C., Yaffe, K., Yang, J. - J., Lee, J. - M., Na, D. L., and Seo, S. Won, “Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1237-1246, 2018.
S. Favaretto, Walter, U., Baracchini, C., and Cagnin, A., “Transcranial Sonography in Neurodegenerative Diseases with Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 1, pp. 29-40, 2018.
G. Di Fede, Giaccone, G., Salmona, M., and Tagliavini, F., “Translational Research in Alzheimer's and Prion Diseases.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1247-1259, 2018.

Pages